You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康泰醫學(300869.SZ)擬發行4100萬股 初步詢價時間為8月5日
格隆匯 07-31 15:00

格隆匯 7 月 31日丨康泰醫學(300869.SZ)發佈首次公開發行股票並在創業板上市發行安排及初步詢價公告,擬公開發行股票4100萬股,發行股份佔公司發行後股份總數的比例為10.20%,全部為公開發行新股,公司股東不進行公開發售股份。此次公開發行後總股本為40179.68萬股。

次發行保薦機構相關子公司跟投的初始比例為此次公開發行數量的5%,初始戰略配售發行數量為205萬股,最終戰略配售數量與初始戰略配售數量的差額將根據“七、回撥機制”的原則進行回撥。

回撥機制啟動前,網下初始發行數量為3116萬股,佔扣除初始戰略配售數量後發行數量的80%;網上初始發行數量為779萬股,佔扣除初始戰略配售數量後發行數量的20%。最終網下網上發行數量受回撥機制的影響,網上及網下最終發行數量將根據回撥情況確定。

次發行的初步詢價時間為202085日(T-3日)9:30-15:00

投資者在2020810日(T日)進行網上和網下申購時無需繳付申購資金。此次網下發行申購日與網上申購日同2020810,其中,網下申購時間為9:30-15:00,網上申購時間9:30-11:3013:00-15:00

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account